Xenon Pharmaceuticals Inc... (XENE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
40.28
0.63 (1.59%)
At close: Jan 15, 2025, 12:54 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
PE Ratio | -16.89 | -19.04 | -17.28 | -18.42 | -8.18 | -3.55 | -1.66 | -5.19 | -7.29 | 4.80 | 7.93 | -22.18 | -7.95 |
PS Ratio | n/a | 253.04 | 73.92 | 16.52 | 49.80 | n/a | 163.66 | 66.17 | 7.37 | 2.20 | 3.49 | 6.67 | 13.78 |
PB Ratio | 3.32 | 3.31 | 2.48 | 3.10 | 3.70 | 1.19 | 1.42 | 1.87 | 1.88 | 0.86 | 3.96 | 7.56 | n/a |
P/FCF Ratio | -20.41 | -23.56 | -19.05 | -10.47 | -57.91 | -3.48 | -1.75 | -6.01 | -6.16 | -49.5 | -27.43 | 2.12 | -6.82 |
P/OCF Ratio | -21.2 | -24.25 | -19.61 | -11.04 | -73.42 | -3.53 | -1.77 | -6.1 | -6.34 | 235.04 | -28.72 | 2.09 | -6.96 |
OCF/S Ratio | n/a | -10.43 | -3.77 | -1.5 | -0.68 | n/a | -92.37 | -10.85 | -1.16 | 0.01 | -0.12 | 3.19 | -1.98 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.18 | 0.15 | 0.19 | n/a | n/a | n/a | n/a | 0.13 | n/a |
Quick Ratio | 23.65 | 26.49 | 39.23 | 12.42 | 3.34 | 29.48 | 10.98 | 18.68 | 21.99 | 5.95 | 2.74 | 3.16 | n/a |
Current Ratio | 23.65 | 26.44 | 39.03 | 12.30 | 3.34 | 29.48 | 10.98 | 18.68 | 21.88 | 5.95 | 2.74 | 3.16 | n/a |
Asset Turnover | n/a | 0.01 | 0.03 | 0.17 | 0.05 | n/a | 0.01 | 0.03 | 0.24 | 0.32 | 0.50 | 0.23 | n/a |
Interest Coverage | n/a | n/a | n/a | -64.67 | -29.86 | -27.27 | n/a | n/a | n/a | n/a | 151.75 | -33.9 | -133.12 |
Return on Equity (ROE) | -0.2 | -0.17 | -0.14 | -0.17 | -0.45 | -0.33 | -0.85 | -0.36 | -0.26 | 0.18 | 0.50 | -0.34 | n/a |
Return on Assets (ROA) | -0.19 | -0.17 | -0.14 | -0.15 | -0.28 | -0.28 | -0.67 | -0.34 | -0.25 | 0.15 | 0.22 | -0.07 | n/a |
Return on Capital (ROIC) | -0.23 | -0.18 | -0.14 | -0.18 | -0.41 | -0.32 | -0.77 | -0.39 | -0.15 | 0.15 | 0.27 | -0.07 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -1.02K% | -309.3% | -57.07% | -468.82% | n/a | -8.12K% | 38.21% | 82.27% | 79.19% | 77.30% | 48.84% | 100.00% |
Net Profit Margin | n/a | -1.33K% | -427.85% | -89.65% | -609.09% | n/a | -9.87K% | -1.28K% | -101.12% | 45.89% | 43.98% | -30.06% | -173.34% |
Pretax Profit Margin | n/a | -1.33K% | -427.88% | -90.45% | -609.43% | n/a | -9.87K% | -1.28K% | -101.12% | 45.89% | 43.98% | -30.06% | -173.34% |
Operating Profit Margin | n/a | -1.37K% | -428.45% | -97.31% | -627.02% | n/a | -10.47K% | -1.38K% | -60.1% | 39.15% | 35.50% | -22.04% | -175.11% |
FCF Margin | n/a | -1.07K% | -388.09% | -157.81% | -85.99% | n/a | -9.34K% | -1.10K% | -119.75% | -4.45% | -12.71% | 314.84% | -202.07% |
EBITDA Margin | n/a | -1.35K% | -423.53% | -86.94% | -582.15% | n/a | -9.66K% | -1.33K% | -53.43% | 41.75% | 38.08% | -23.92% | -155.67% |